Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...

The deal adds to a rapidly-expanding pipeline of NASH candidates at Novo Nordisk, which also includes GLP-1 analogue semaglutide in phase 3 in combination with drugs from Gilead, a long-acting ...

Greg Grandin is Pulitzer Prize–winning historian, author of many books including The End of the Myth, The Empire of Necessity, Fordlandia; and his forthcoming, América, América: A New History of the ...

A Social Security award letter is the document used to notify ... These payments help cover the loss of income due to the individual’s health condition and inability to work.

Kohl's Corp.-1.18% $1.32B ...

This advertisement has not loaded yet, but your article continues below.